Advances in cancer pain management

Hematol Oncol Clin North Am. 2002 Jun;16(3):527-41. doi: 10.1016/s0889-8588(02)00016-3.

Abstract

Although most patients with cancer pain can attain a favorable balance between analgesia and side effects with a conventional approach to opioid therapy, a substantial minority cannot. For these patients, an important subgroup of whom have neuropathic pain, alternative therapeutic strategies are needed. With a detailed assessment, clinicians should be able to choose among the large and diverse group of options available and implement an approach, or combination of approaches, that have a high probability of improving analgesic outcomes.

Publication types

  • Review

MeSH terms

  • Analgesics, Opioid / adverse effects
  • Analgesics, Opioid / therapeutic use*
  • Anesthetics, Local / therapeutic use
  • Anti-Inflammatory Agents / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Anticonvulsants / therapeutic use
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Humans
  • Neoplasms / complications*
  • Pain / diagnosis
  • Pain / drug therapy*
  • Pain / etiology*
  • Pain Measurement
  • Palliative Care / methods
  • Patient Care Planning
  • Patient Selection
  • Psychotropic Drugs / therapeutic use
  • Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors
  • Steroids
  • Treatment Outcome

Substances

  • Analgesics, Opioid
  • Anesthetics, Local
  • Anti-Inflammatory Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Anticonvulsants
  • Psychotropic Drugs
  • Receptors, N-Methyl-D-Aspartate
  • Steroids